Epidemiology of urinary tract infections caused by extended-spectrum beta-lactamase-producing Escherichia coli

Urology

Volumn 68, Issue 6, 2006, Pages 1169-1174

  Ena, Javier ^a   Arjona, Francisco ^a   Martínez Peinado, Carmen ^a   del mar López Perezagua, Maria ^a   Amador, Concepción ^a  

^a HOSPITAL MARINA BAIXA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

CARBAPENEM; EXTENDED SPECTRUM BETA LACTAMASE; FOSFOMYCIN; QUINOLONE DERIVATIVE;

AGED; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM ISOLATE; BACTERIUM ISOLATION; CONFIDENCE INTERVAL; DISEASE ASSOCIATION; ENTEROBACTER INFECTION; ESCHERICHIA COLI; FEMALE; HEALTH CENTER; HUMAN; INFECTION RATE; INFECTION RISK; MAJOR CLINICAL STUDY; MALE; MEDICAL ASSESSMENT; MEDICAL RECORD; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RETROSPECTIVE STUDY; RISK ASSESSMENT; RISK FACTOR; TREND STUDY; URINALYSIS; URINARY TRACT INFECTION; URINE CATHETER;

AGED; BETA-LACTAMASES; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTIONS; FEMALE; FOLLOW-UP STUDIES; HUMANS; INCIDENCE; MALE; RETROSPECTIVE STUDIES; RISK FACTORS; SPAIN; URINARY TRACT INFECTIONS; URINE;

EID: 33845405313     PISSN: 00904295     EISSN: 15279995     Source Type: Journal    
DOI: 10.1016/j.urology.2006.08.1075     Document Type: Article

References (20)

1. Paterson D.L., Ko W.C., Von Gottberg A., et al. Outcome of cephalosporin treatment for serious infection due to apparently susceptible organisms producing extended-spectrum β-lactamases: implications for the clinical microbiology laboratory. J Clin Microbiol 39 (2001) 2206-2212
2. Centers for Disease Control and Prevention: Laboratory detection of extended-spectrum β-lactamases (ESBLs). Available at: http://www.cdc.gov/ncidod/hip/Lab/FactSheet/esbl.htm. Accessed November 30, 2002.
3. Wiener J., Quinn J.P., Bradford P.A., et al. Multiple antibiotic-resistant Klebsiella and Escherichia coli in nursing homes. JAMA 281 (1999) 517-523
4. Kanafani Z.A., Mehio-Sibai A., Araj G.F., et al. Epidemiology and risk factors for extended-spectrum β-lactamase producing organisms: a case control study at a tertiary care center in Lebanon. Am J Infect Control 33 (2005) 326-332
5. Goldstein F.W., and Multicenter Study Group. Antibiotic susceptibility of bacterial strains isolated from patients with community-acquired urinary tract infections in France. Eur J Clin Microbiol Infect Dis 19 (2000) 112-117
6. Hryniewicz K., Szcypa K., Sulikowska A., et al. Antibiotic susceptibility of bacterial strains isolated from urinary tract infections in Poland. J Antimicrob Chemother 47 (2001) 773-780
7. Rodriguez-Baño J., Navarro M.D., Romero L., et al. Epidemiology and clinical features of infections caused by expended-spectrum beta-lactamase-producing Escherichia coli in nonhospitalized patients. J Clin Microbiol 42 (2004) 1089-1094
8. Colodner R., Rock W., Chazan B., et al. Risk factors for the development of extended-spectrum beta-lactamase-producing bacteria in nonhospitalized patients. Eur J Clin Microbiol Infect Dis 23 (2004) 163-167
9. Charlson M., Szatrowski T.P., Peterson J., et al. Validation of a combined comorbidity index. J Clin Epidemiol 47 (1994) 1245-1251
10. National Committee for Clinical Laboratory Standards. Performance Standards for Antimicrobial Susceptibility Testing, 12th Informational Supplement (2002), NCCLS, Wayne, PA NCCLS document M100-S12.
11. Jarlier V., Nicolas M.H., Fournier G., et al. Extended broad-spectrum beta-lactamases conferring transferable resistance to newer beta-lactam agents in Enterobacteriaceae: hospital prevalence and susceptibility patterns. Rev Infect Dis 10 (1988) 867-878
12. Schlesselman J.J. Case-Control Studies: Design, Conduct, Analysis (1982), Oxford University Press, New York
13. Winokur P.L., Canton R., Casellas J.M., et al. Variations in the prevalence of strains expressing an extended-spectrum β-lactamase phenotype and characterization of isolates from Europe, the Americas, and the Western Pacific Region. Clin Infect Dis 32 suppl 2 (2001) S94-S103
14. Itokazu G.S., Quinn J.P., Bell-Dixon C., et al. Antimicrobial resistance rates among aerobic gram-negative bacilli recovered from patients in intensive care units: evaluation of a national postmarketing surveillance program. Clin Infect Dis 23 (1996) 779-784
15. Hyle E.P., Lipworth A.D., Zaoutis T.E., et al. Impact of inadequate initial antimicrobial therapy on mortality in infections due to extended-spectrum β-lactamase-producing enterobacteriaceae. Arch Intern Med 165 (2005) 1375-1380
16. Navon-Venezia S., Ben-Ami R., Schwaber M.J., et al. Protocol for the accelerated detection of extended-spectrum β-lactamase-producing Escherichia coli and Klebsiella pneumoniae strains from blood cultures. Eur J Clin Microbiol Infect Dis 23 (2004) 200-202
17. Yagüe A., Cebrian L., Rodriguez-Diaz J.C., et al. Expanded-spectrum beta-lactamase-producing strains of E. coli: origin, characteristics and incidence in southern Alicante (Spain) in the period 1999-2003. Enferm Infecc Microbiol Clin 23 (2005) 76-79
18. Andreu A., Alos J.I., Gobernado M., et al. Etiology and antimicrobial susceptibility among uropathogens causing community-acquired lower urinary tract infections: a nationwide surveillance study. Enferm Infecc Microbiol Clin 23 (2005) 4-9
19. Lautenbach E., Patel J.B., Bilker W.B., et al. Extended-spectrum β-lactamase producing Escherichia coli and Klebsiella pneumoniae: risk factors for infection and impact of resistance on outcomes. Clin Infect Dis 32 (2001) 1162-1171
20. Walker S., McGeer A., Simor A.E., et al. Why are antibiotics prescribed for asymptomatic bacteriuria in institutionalized elderly people?. Can Med Assoc J 163 (2000) 273-277